β3A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter

Molecular and Cellular Biology

Volumn 21, Issue 6, 2001, Pages 2118-2132

  Hapke, Sandra ^a   Gawaz, Meinrad ^b   Dehne, Kerstin ^a   Köhler, Jenny ^a   Marshall, John F ^c   Graeff, Henner ^a   Schmitt, Manfred ^a   Reuning, Ute ^a   Lengyel, Ernst ^a,d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; BETA3 INTEGRIN; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; BASE SEQUENCE; BINDING SITES; CHO CELLS; CRICETINAE; CYTOPLASM; DOWN-REGULATION; GENE EXPRESSION REGULATION; INTEGRIN BETA3; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PLATELET MEMBRANE GLYCOPROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION, GENETIC;

ANIMALIA; RICKETTSIA SP. PAR;

EID: 0035015311     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.6.2118-2132.2001     Document Type: Article

References (62)

1. Akiyama, S. K., S. S. Yamada, K. M. Yamada, and S. E. La Flamme. 1999. Transmembrane signal transduction by integrin cytoplasmic domains expressed in single-subunit chimeras. J. Biol. Chem. 269:15961-15964.
2. Allgayer, H., H. Wang, Y. Wang, M. M. Heiss, R. Bauer, O. Nyormoi, and D. Boyd. 1999. Transactivation of the urokinase-type plasminogen activator receptor gene through a novel promoter motif bound with an activator protein-2α-related factor. J. Biol. Chem. 274:47012-4714.
3. Benbow, U., and C. E. Brinckerhoff. 1998. The Ap-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15:519-526.
4. Bergers, G., and L. Coussens. 2000. Extrinsic regulators of epithelial tumor progression: metalloproteinases. Curr. Opin. Genet. Dev. 10:120-127.
5. Blasi, F. 1999. Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system. Thromb. Haemostasis 82:298-304.
6. Bohuslav, J., V. Horejsi, C. Hansmann, J. Stockl, U. H. Weidle, O. Majdic, I. Bartke, W. Knapp, and H. Slockinger. 1995. Urokinase plasminogen activator receptor. β2-integrins, and src-kinases within a single receptor complex of human monocytes. J. Exp. Med. 181:1381-1390.
7. Chapman, H. 1997. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9:714-724.
8. Chen, Q., M. S. Kinch, T. H. Lin, K. Burridge, and R. L. Juliano. 1994. Integrin-medialed cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem 269:26602-26605.
9. Clark, E. A., and J. S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
10. Conese, M., A. Nykjaer, C. M. Petersen, P. A. Andreasen, J. Gliemann, E. I. Christensen, and F. Blasi. 1995. α-2 Macroglobulin receptor/LDL receptor-related protein (Lrp)-dependent internalization of the urokinase receptor. J. Cell Biol. 131:1609-1622.
11. Danen, E. H. J., A. A. van Kraats, I. M. H. A. Cornelissen, D. J. Ruiter, and G. N. P. van Muijen. 1996. Integrin β3 cDNA transfection into a highly metastatic αvβ.3-negative human melanoma cell line inhibits invasion and experimental metastasis. Biochem. Biophys. Res. Commun. 226:75-81.
12. 3-endonexin. J. Biol. Chem. 272:7693-7698.
13. Ellis, V., N. Behrendt, and K. Dano. 1991. Plasminogen activation by receptor-bound urokinase. J. Biol. Chem. 266:12752-12758.
14. Fowler, B., N. Mackman, R. J. Parmer, and L. A. Miles. 1998 Binding of human single chain urokinase to Chinese hamster ovary cells and cloning of hamster u-PAR. Thromb. Haemostasis 80:148-154.
15. 3 (platelet GPIIB-IIIA) dependent homotypic and heterotypic cell-cell interactions. J. Clin. Investig. 88:1128-1134.
16. 3-integrin A form. J. Cell Sci., in press.
17. Ghiso, J. A., K. Kovalski, and L. Ossowski. 1999. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J. Cell Biol. 147:89-103.
18. Goldberg, Y., M. Treier, J. Ghysdael, and D. Bohmann. 1994. Repression of AP-1 stimulated transcription by c-Ets-1. J. Biol. Chem. 269:16566-16573.
19. Graves, B., and J. Petersen. 1998. Specificity within the ets family of transcription factors. Adv. Cancer Res. 75:1-55.
20. Gum, R., C. Juarez, H. Allgayer, A. Mazar, Y. Wang, and D. Boyd. 1998. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules. Oncogene 17:213-225.
21. Gum, R., E. Lengyel, J. Juarez, J. H. Chen, H. Sato, M. Seiki, and D. Boyd. 1996. Stimulation of 92-kDA gelatinase B promoter activity by ras is mitogen-aetivated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences, J. Biol. Chem. 271:10672-10680.
22. Hemler, M. E. 1998. Integrin associated proteins. Curr. Opin. Cell Biol, 10: 578-585.
23. 3 integrin cytoplasmic tail. J. Cell Biol. 137:1433-1443.
24. Kolanus, W., C. Romeo, and B. Seed. 1993. T cell activation by clustered tyrosine kinases. Cell 74:171-183.
25. LaFlamme, S. E., S. M. Homan, A. L. Bodeau, and M. Mastrangelo. 1997. Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus. Matrix Biol. 16:153-163.
26. Lengyel, E., H. Wang, R. Gum, C. Simon, Y. Wang, and D. Boyd. 1997. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular-signal regulated kinase 1 dependent signaling cascade. Oncogene 14:2563-2574.
27. Lengyel, E., H. Wang, E. Stepp, J. Juarez, Y. Wang, W. F. Doe, C. M. Pfarr, and D. Boyd. 1996. Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene. J. Biol. Chem. 271:23176-23184.
28. Liotta, L., R. Goldfarb, R. Brundage, G. Siegel, V. Terranova, and S. Garnisa. 1981. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 41:4621-4636.
29. 3 integrin mutation abolishes ligand binding and alters divalent cation-dependent conformation. Science 249:915-918.
30. Lund, L. R., V. Ellis, E. Ronne, C. Pyke, and K. Dano. 1995. Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumor promoters in the human lung carcinoma cell line A549. Biochem. J. 310:345-352.
31. Marshall, J. F., and I. R. Hart. 1996. The role of αv-integrins in tumour progression and metastasis. Semin. Cancer Biol. 7:129-138.
32. Morgenstern, J. P., and H. Land. 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587-3596.
33. Morimoto, A. M., K. C. Jordan, K. Tietze, J. S. Britton, E. M. O'Neill, and H. Ruohola-Baker. 1995. Pointed, an ETS domain transcription factor, negatively regulates the EGF receptor pathway in Drosophila oogenesis. Development 122:3745-3754.
34. Needham, G. K., G. V. Sherbet, J. R. Farndon, and A. L. Harris. 1986. Binding of urokinase to specific receptor sites on human breast cancer membranes. Br. J. Cancer 55:13-16.
35. Nerlov, C., P. Rorth, F. Blasi, and M. Johnsen. 1991. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1593.
36. Ploug, M., H. Rahbeck-Nielsen, P. Nielsen, P. Roepstorff, and K. Dano. 1998. Glycosylation profile of a recombinant urokinase-type plasminogen activator expressed in Chinese hamster ovary cells. J. Biol. Chem. 273:13933-13943.
37. Preissner, K. T., S. M. Kanse, T. Chavakis, and A. E. May. 1999. The dual role of the urokinase receptor system in pericellular proteolysis and cell adhesion: implications for cardiovascular function. Basic Res. Cardiol. 94: 315-319.
38. Pyke, C., J. Eriksen, H. Solberg, B. Schnack, S. Nielsen, P. Kristensen, L. R. Lund, and K. Dano. 1993. An alternatively spliced variant of mRNA of the human receptor for urokinase plasminogen activator. FEBS Lett 326:69-74.
39. Ried, S., C. Jäger, G. F. Vande Woude, H. Graeff, M. Schmitt, and E. Lengyel. 1999. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor (HGF/SF). J. Biol. Chem. 274:16377-16386.
40. Riikonen, T., J. Westermarck, L. Koivisto, A. Broberg, V.-M. Kähäri, and J. Heino. 1995. Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J. Biol. Chem. 270:13548-13552.
41. 3, integrin cytoplasmic domain tyrosine residues 747 and 759 in integrin-mediated cytoskeletal assembly and phosphotyrosine signaling. J. Biol. Chem. 278:12623-12632.
42. Schneikert, J., H. Peterziel, P. A. Defossez, H. Klocker, Y. Launoit, and A. C. Cato. 1996. Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J. Biol. Chem. 271:23907-23913.
43. Schnelzer, A., D. Prechtel, U. Knaus, K. Dehne, M. Gerhard, H. Graeff, N. Harbeck, M. Schmitt, and E. Lengyel. 2000. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19:3013-3020.
44. Schvartz, I., D. Seger, and S. Shaltiel. 1999. Vitronectin. Int. J. Biochem. Cell Biol. 31:539-544.
45. 3, integrin subunit in human primary melanoma progression. Am. J. Pathol. 153:1347-1351.
46. 3 subunit. J. Cell Biol. 131:807-816.
47. Sheety, S., A. Kumar, and S. Idell. 1997. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol. 17: 1075-1083.
48. Simon, D. I., N. K. Rao, H. Xu, Y. Wei, O. Majdic, E. Ronne, L. Kobzik, and H. Chapman. 1996 Mac-1 (CD11WCD18) and the urokinase receptor (CD 87) form a functional unit on monocytic tells. Blood 88:3185-3194.
49. Soravia, E., A. Grebe, P. De Luca, K. Helin, T. T. Suh, J. L. Degen, and F. Blasi. 1995. A conserved TATA-less proximal promoter drives basal transcription from the urokinase-type piasminogen activator receptor gene. Blood 86:624-635.
50. Turkson, J., T. Bowman, R. Garcia, E. Caldenhoven, R. P. de Groat, and R. Jove. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545-2552.
51. 3, subunit. Proc. Natl. Acad. Sci. USA 86:541.5-5418.
52. Wasylyk, B., S. Hahn, and A. Giovane. 1993. The Ets family of transcription factors. Eur. J. Biochem. 211:7-18.
53. Wei, Y., M. Lukashev, D. I. Simon, S. C. Bodary, S. Rosenberg, M. V. Doyle, and H. Chapman. 1996. Regulation of integrin function by the urokinase receptor. Science 273:1551-1555.
54. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
55. Westermarck, J., and V.-M. Kähäri. 1999. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13:781-792.
56. Woodhouse, E. C., R. F. Chuaqui, and L. Liotta. 1997. General mechanisms of metastasis. Cancer 80:1529-1537.
57. Xin, J., A. Cowie, P. Lachance, and J. A. Hassell. 1992. Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells. Genes Dev. 6:481-496.
58. Xing, X., S. W. Wang, W. Xia, et al. 2000. The Ets protein PEA3 suppresses Her2/neu overexpression and inhibits tumorigenesis. Nat. Med. 6:189-195.
59. 3, integrins of fibrosarcoma cells: dependence on extracellular matrix components. Cancer Res. 57:1582-1689.
60. Yebra, M., L. Goretzki, M. Pfeifer, and B. Mutiler. 1999. Urokinase-type plasminogen activator hindingto its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp. Cell Res. 250:231-240.
61. Ylänne, J. 1999. Conserved functions of the cyloplasmic domains of integrin heta subunits. Front. Biosci. 3:877-886.
62. Zheng, B., and R. D. Clemmons. 1998. Blocking ligand occupancy of the αv3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle ecus. Proc. Natl. Acad. Sci. USA 95:11217-11222.